Information Provided By:
Fly News Breaks for April 13, 2016
SYK
Apr 13, 2016 | 08:33 EDT
As previously reported, Baird analyst Jeff Johnson downgraded Stryker to Neutral from Outperform, saying that the risk/reward for the shares looks increasingly balanced after the stock's recent outperformance relative to the group. The analyst, who thinks Stryker's current premium to ortho peers seems warranted, raised his price target on the stock to $116 from $111.